PGP9.5 as a prognostic factor in pancreatic cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 11156232.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The expression of PGP9.5 was evaluated using immunohistochemistry in 69 resected ductal carcinomas of the pancreas and in normal pancreatic tissue. Overexpression did not seem to differ with histological type or pathological stage. A significant negative correlation was found between overexpression of PGP9.5 and postoperative survival. Multivariate analysis also suggested PGP9.5 along with tumor stage and extrapancreatic plexus invasion as strong predictors of the outcome. This study suggests that PGP9.5 expression may be used as a marker for predicting the outcome of resection-treated pancreatic cancer patients.
Medical subject headings
- Antigens, Differentiation
- Carcinoma, Pancreatic Ductal
- Pancreatic Neoplasms